MedTrace Logo

Pain During Femoral Sheath Removal in Patients Undergoing Percutaneous Coronary Intervenion

NCT06445387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 108

Last updated 2024-06-06

No results posted yet for this study

Summary

It is to examine the effect of virtual reality and ice application on the pain level due to femoral sheath extraction.

Conditions

  • Percutaneous Coronary Intervention
  • Virtual Reality
  • Nursing Caries
  • Cryotherapy
  • Pain Management

Interventions

OTHER

Virtual Reality Glasses

Preparation Stage of Virtual Glasses: A 20-minute video consisting of nature scenes shot with a 360-degree camera was selected by the researchers from YouTube. Permission was obtained from the person who created the video. For the selection of music, both the music that is good for diseases were examined in the literature and an expert opinion was taken from a faculty member (Phd, assistant professor) working at the Faculty of Music and Fine Arts of a university. The music used in the video was created with works selected from the Hüseyni maqam.

OTHER

Ice Application Group

Features of the ice and ice bag used for patients in ice application; Ice cubes with dimensions of 9.5 x 26 x 3.5 cm were used. The ice bag is made of cotton and polyester coated fabric and is easily bendable. In this way, the ice bag was ensured to fit properly to the patient's femoral region. It is reusable and heat insulated. The procedure was carried out by following the cold application step protocol created by the researchers using the literature.

OTHER

Control Group

They continued to receive their routine treatment and care. No changes were made in their routine treatment and care.

Sponsors & Collaborators

  • Amasya University

    lead OTHER

Principal Investigators

  • Eylem Topbaş, Phd · Amasya University Faculty of Health Science

  • Gökhan KESKİN, Phd · Amasya University Faculty of Medical Science

  • Aycan SOYLU, Msc · Amasya University Instutue of Health Science

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-12
Primary Completion
2022-11-03
Completion
2023-01-04

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06445387 on ClinicalTrials.gov